Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models
Authors:
Open Access
- 15 May 2001
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 166 (10) , 6341-6348
Abstract
The anaphylatoxin C3a is a potent chemotactic peptide and inflammatory mediator released during complement activation which binds to and activates a G-protein-coupled receptor. Molecular cloning of the C3aR has facilitated studies to identify nonpeptide antagonists of the C3aR. A chemical lead that selectively inhibited the C3aR in a high throughput screen was identified and chemically optimized. The resulting antagonist, N2-[(2,2-diphenylethoxy)acetyl]-l-arginine (SB 290157), functioned as a competitive antagonist of 125I-C3a radioligand binding to rat basophilic leukemia (RBL)-2H3 cells expressing the human C3aR (RBL-C3aR), with an IC50 of 200 nM. SB 290157 was a functional antagonist, blocking C3a-induced C3aR internalization in a concentration-dependent manner and C3a-induced Ca2+ mobilization in RBL-C3aR cells and human neutrophils with IC50s of 27.7 and 28 nM, respectively. SB 290157 was selective for the C3aR in that it did not antagonize the C5aR or six other chemotactic G protein-coupled receptors. Functional antagonism was not solely limited to the human C3aR; SB 290157 also inhibited C3a-induced Ca2+ mobilization of RBL-2H3 cells expressing the mouse and guinea pig C3aRs. It potently inhibited C3a-mediated ATP release from guinea pig platelets and inhibited C3a-induced potentiation of the contractile response to field stimulation of perfused rat caudal artery. Furthermore, in animal models, SB 290157, inhibited neutrophil recruitment in a guinea pig LPS-induced airway neutrophilia model and decreased paw edema in a rat adjuvant-induced arthritis model. This selective antagonist may be useful to define the physiological and pathophysiological roles of the C3aR.Keywords
This publication has 30 references indexed in Scilit:
- Complement anaphylatoxin receptors on neurons: new tricks for old receptors?Trends in Neurosciences, 1999
- Characterization of Complement Anaphylatoxins and Their Biological Responses1998
- Evidence that the receptor for C4a is distinct from the C3a receptorImmunopharmacology, 1997
- Persistent Airway Eosinophilia After Leukotriene (LT) D4 Administration in the Guinea Pig: Modulation by the LTD4 Receptor Antagonist, Pranlukast, or an Interleukin-5 Monoclonal AntibodyAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U‐937 cellsEuropean Journal of Immunology, 1996
- Molecular Cloning and Characterization of the Human Anaphylatoxin C3a ReceptorJournal of Biological Chemistry, 1996
- cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structureBiochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1996
- C3a is a chemotaxin for human eosinophils but not for neutrophils. I. C3a stimulation of neutrophils is secondary to eosinophil activation.Journal of Experimental Medicine, 1995
- Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis‐toxin‐sensitive G proteinEuropean Journal of Biochemistry, 1993
- Microprocessor-assisted plethysmograph for the measurment of mouse paw volumeJournal of Pharmacological Methods, 1984